Drug
Plasmin
Plasmin: highest development phase Phase 2, developed by Grifols. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| Plasmin NCT01222117 | Phase 2 | Acute Peripheral Arterial Occlusion |
Latest
No recent events.
Follow Plasmin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.